Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

Published:2016-12 Issue:12 Volume:17 Page:1732-1742
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mir Olivier,Brodowicz Thomas,Italiano Antoine,Wallet Jennifer,Blay Jean-Yves,Bertucci François,Chevreau Christine,Piperno-Neumann Sophie,Bompas Emmanuelle,Salas Sébastien,Perrin Christophe,Delcambre Corinne,Liegl-Atzwanger Bernadette,Toulmonde Maud,Dumont Sarah,Ray-Coquard Isabelle,Clisant Stéphanie,Taieb Sophie,Guillemet Cécile,Rios Maria,Collard Olivier,Bozec Laurence,Cupissol Didier,Saada-Bouzid Esma,Lemaignan Christine,Eisterer Wolfgang,Isambert Nicolas,Chaigneau Loïc,Cesne Axel Le,Penel Nicolas

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing;Ducimetière;PLoS One,2011

2. Soft-tissue sarcomas in adults;Clark;N Engl J Med,2005

3. Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Ann Oncol,2014

4. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens as first-line and second-line chemotherapy in advanced soft tissue sarcoma patients;Van Oosterom;Eur J Cancer,2002

5. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules;Demetri;J Clin Oncol,2009

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion complexes of regorafenib with beta- and gamma-cyclodextrin derivatives: In silico and in vitro studies;Journal of Molecular Liquids;2024-10

2. Molecular characteristics and systemic treatment options of liposarcoma: A systematic review;Biomedicine & Pharmacotherapy;2024-09

3. Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy;BMC Cancer;2024-08-20

4. Regorafenib-induced Myopathy;Internal Medicine;2024-08-15

5. Setting the international research agenda for sarcomas with patients and carers: results of phase II of the Sarcoma Patient Advocacy Global Network (SPAGN) priority setting partnership;BMC Cancer;2024-08-06